OmiCure

Curated by Signal

Provider of diagnostic solutions for cancer patients

Overview

OmiCure provides diagnostic solutions for cancer patients. The AI-based platform helps professionals to assess their patient's tumor activity by delivering personalized drugs for targeted mutation. The drugs and the cancer treatments are chosen based on tumor profiling done for the patients and gives insights for better treatment and diagnostic approaches for the oncologists.

Key facts

Founded: 2003
Headquarters: Cambridge, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

4 products and services: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

Celavet
Develops stem cell therapy for equine animals
Life Sciences TechnologyReading, United States
GRIN-X
Provider of an integrative bioinformatics platform for genetic analysis
Life Sciences TechnologyTucson, United States
AMI Cardiac Monitoring
Developer of cardiac health monitoring devices
Life Sciences TechnologyRockville, United States

About OmiCure

What does OmiCure do?

OmiCure provides diagnostic solutions for cancer patients.

Where is OmiCure headquartered?

OmiCure is headquartered in Cambridge, United States.

When was OmiCure founded?

OmiCure was founded in 2003.

Which sector is OmiCure in?

OmiCure operates in Life Sciences Technology.

Who are OmiCure's competitors?

Companies similar to OmiCure include Celavet, GRIN-X, and AMI Cardiac Monitoring.